Patent 9447070 was granted and assigned to Celgene on September, 2016 by the United States Patent and Trademark Office.
This invention relates to 5-substituted isoindoline compounds, and pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.